256 related articles for article (PubMed ID: 2170840)
1. Somatostatin-receptor imaging in the localization of endocrine tumors.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
N Engl J Med; 1990 Nov; 323(18):1246-9. PubMed ID: 2170840
[TBL] [Abstract][Full Text] [Related]
2. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
[TBL] [Abstract][Full Text] [Related]
3. Use of isotope-labeled somatostatin analogs for visualization of islet cell tumors.
van Eyck CH; Bruining HA; Reubi JC; Bakker WH; Oei HY; Krenning EP; Lamberts SW
World J Surg; 1993; 17(4):444-7. PubMed ID: 8395748
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin-receptor imaging for the detection of tumors.
Patel YC
N Engl J Med; 1990 Nov; 323(18):1274-6. PubMed ID: 2170841
[No Abstract] [Full Text] [Related]
5. Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors.
Kvols LK; Brown ML; O'Connor MK; Hung JC; Hayostek RJ; Reubi JC; Lamberts SW
Radiology; 1993 Apr; 187(1):129-33. PubMed ID: 8383865
[TBL] [Abstract][Full Text] [Related]
6. Treatment with Sandostatin and in vivo localization of tumors with radiolabeled somatostatin analogs.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
Metabolism; 1990 Sep; 39(9 Suppl 2):152-5. PubMed ID: 2169572
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
8. In vivo somatostatin receptor imaging in the detection and treatment of gastrointestinal cancer.
Schubert ML
Gastroenterology; 1991 Apr; 100(4):1143-4. PubMed ID: 1848196
[No Abstract] [Full Text] [Related]
9. [A new imaging procedure for detecting endocrine tumors].
Schäffer M; Fölsch UR
Z Gastroenterol; 1991 Apr; 29(4):173-4. PubMed ID: 1651031
[No Abstract] [Full Text] [Related]
10. The visualization of gastroenteropancreatic endocrine tumors.
Lamberts SW; Chayvialle JA; Krenning EP
Digestion; 1993; 54 Suppl 1():92-7. PubMed ID: 8395433
[TBL] [Abstract][Full Text] [Related]
11. Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide.
Nocaudie-Calzada M; Huglo D; Deveaux M; Carnaille B; Proye C; Marchandise X
J Nucl Med; 1994 Jan; 35(1):57-62. PubMed ID: 8271061
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin receptor imaging of endocrine gastrointestinal tumors.
Krenning EP; Kwekkeboom DJ; Oei HY; Reubi JC; van Hagen PM; Kooij PP; Reijs AE; Lamberts SW
Schweiz Med Wochenschr; 1992 Apr; 122(17):634-7. PubMed ID: 1350377
[TBL] [Abstract][Full Text] [Related]
13. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors.
Lamberts SW; Reubi JC; Krenning EP
Acta Oncol; 1993; 32(2):167-70. PubMed ID: 8391830
[TBL] [Abstract][Full Text] [Related]
14. The visualization of gastroenteropancreatic endocrine tumors.
Lamberts SW; Chayvialle JA; Krenning EP
Metabolism; 1992 Sep; 41(9 Suppl 2):111-5. PubMed ID: 1355584
[TBL] [Abstract][Full Text] [Related]
15. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
[TBL] [Abstract][Full Text] [Related]
16. Octreotide scintigraphy localizes somatostatin receptor-positive islet cell carcinomas.
Becker W; Marienhagen J; Scheubel R; Saptogino A; Bakker WH; Breeman WA; Wolf F
Eur J Nucl Med; 1991; 18(11):924-7. PubMed ID: 1684323
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors.
Virgolini I; Raderer M; Kurtaran A; Angelberger P; Banyai S; Yang Q; Li S; Banyai M; Pidlich J; Niederle B; Scheithauer W; Valent P
N Engl J Med; 1994 Oct; 331(17):1116-21. PubMed ID: 7935635
[TBL] [Abstract][Full Text] [Related]
18. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
Bomanji J; Mather S; Moyes J; Ellison D; Grossman A; Britton KE; Besser GM
J Nucl Med; 1992 Jun; 33(6):1121-4. PubMed ID: 1597726
[TBL] [Abstract][Full Text] [Related]
19. Use of radiolabeled somatostatin analogs in the identification and treatment of somatostatin receptor-bearing tumors.
Hurst RD; Modlin IM
Digestion; 1993; 54 Suppl 1():88-91. PubMed ID: 8359574
[TBL] [Abstract][Full Text] [Related]
20. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
Weinel RJ; Kisker O; Joseph K; Welcke U; Zaraca F; Rothmund M
Chirurg; 1994 Oct; 65(10):849-55. PubMed ID: 7821043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]